Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

766 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Labopin M, Tura S, Arcese W, Iriondo A, Zittoun R, Sierra J, Gorin NC. Ringdén O, et al. Br J Haematol. 1996 Jun;93(3):637-45. doi: 10.1046/j.1365-2141.1996.d01-1681.x. Br J Haematol. 1996. PMID: 8652385
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harrousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC. Ringdén O, et al. Bone Marrow Transplant. 1996 Nov;18(5):921-9. Bone Marrow Transplant. 1996. PMID: 8932846
The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Hermans J, Labopin M, Apperley J, Gorin NC, Gratwohl A. Ringdén O, et al. Leuk Lymphoma. 1996 Dec;24(1-2):71-9. doi: 10.3109/10428199609045715. Leuk Lymphoma. 1996. PMID: 9049963 Clinical Trial.
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC. Ringdén O, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):733-4. doi: 10.1016/s0041-1345(96)00443-5. Transplant Proc. 1997. PMID: 9123501 No abstract available.
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Ringdén O, Labopin M, Gluckman E, Hows JM, Bradley BA, Kolb HJ, Fouillard L, Jacobsen N, Vernant JP, Witz F, Harousseau JL, Gorin NC. Ringdén O, et al. Bone Marrow Transplant. 1997 May;19(10):963-8. doi: 10.1038/sj.bmt.1700787. Bone Marrow Transplant. 1997. PMID: 9169639
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Ringdén O, Remberger M, Carlens S, Hagglund H, Mattsson J, Aschan J, Lönnqvist B, Klaesson S, Winiarski J, Dalianis T, Olerup O, Sparrelid E, Elmhorn-Rosenborg A, Svahn BM, Ljungman P. Ringdén O, et al. Transplantation. 1998 Sep 15;66(5):620-5. doi: 10.1097/00007890-199809150-00013. Transplantation. 1998. PMID: 9753343
766 results